Recognition of pharmacophore of ar-turmerone for its anticancer activity

Abstract

For the evaluation of the role of α,β-unsaturated ketone portion of ar-turmerone for its activity, the structural variation of this structural unit was performed to omit its alkylating property. Thus compounds2, 3, and4 were prepared and their cytotoxicities were determined against three different leukemia cell lines (HL-60, K-562, and L1210)in vitro. The biological inactivity against three different cell lines of these analogues implies that the α,β-unsaturated ketone of ar-turmerone is the essential pharmacophore for its activity.